Mendelian randomization analysis substantiated the significant effects of increased expression of DNA damage-related signatures on liver fat percentage and plasma ALT levels in humans, thereby highlighting the causal role of DNA damage in the pathogenesis of MASLD/MASH. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.